ATE39936T1 - Verfahren zur herstellung eines polymers oder copolymers aus milchsaeure und/oder glycolsaeure. - Google Patents

Verfahren zur herstellung eines polymers oder copolymers aus milchsaeure und/oder glycolsaeure.

Info

Publication number
ATE39936T1
ATE39936T1 AT85304734T AT85304734T ATE39936T1 AT E39936 T1 ATE39936 T1 AT E39936T1 AT 85304734 T AT85304734 T AT 85304734T AT 85304734 T AT85304734 T AT 85304734T AT E39936 T1 ATE39936 T1 AT E39936T1
Authority
AT
Austria
Prior art keywords
copolymer
polymer
production
acid
lactic acid
Prior art date
Application number
AT85304734T
Other languages
English (en)
Inventor
Motoaki Tanaka
Yasuaki Ogawa
Tsutomu Miyagawa
Toshio Watanabe
Original Assignee
Wako Pure Chem Ind Ltd
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15266918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE39936(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP59140356A external-priority patent/JPH0678425B2/ja
Application filed by Wako Pure Chem Ind Ltd, Takeda Chemical Industries Ltd filed Critical Wako Pure Chem Ind Ltd
Application granted granted Critical
Publication of ATE39936T1 publication Critical patent/ATE39936T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
AT85304734T 1984-07-06 1985-07-03 Verfahren zur herstellung eines polymers oder copolymers aus milchsaeure und/oder glycolsaeure. ATE39936T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59140356A JPH0678425B2 (ja) 1984-07-06 1984-07-06 重合体の新規製造法
EP85304734A EP0172636B2 (de) 1984-07-06 1985-07-03 Verfahren zur Herstellung eines Polymers oder Copolymers aus Milchsäure und/oder Glycolsäure

Publications (1)

Publication Number Publication Date
ATE39936T1 true ATE39936T1 (de) 1989-01-15

Family

ID=15266918

Family Applications (2)

Application Number Title Priority Date Filing Date
AT85304734T ATE39936T1 (de) 1984-07-06 1985-07-03 Verfahren zur herstellung eines polymers oder copolymers aus milchsaeure und/oder glycolsaeure.
AT85304733T ATE39935T1 (de) 1984-07-06 1985-07-03 Copolymer und verfahren zu seiner herstellung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT85304733T ATE39935T1 (de) 1984-07-06 1985-07-03 Copolymer und verfahren zu seiner herstellung.

Country Status (8)

Country Link
US (2) US4677191A (de)
EP (2) EP0171907B2 (de)
AT (2) ATE39936T1 (de)
BG (1) BG61520B2 (de)
CA (2) CA1256638A (de)
DE (2) DE3567470D1 (de)
HK (1) HK19592A (de)
SG (1) SG108191G (de)

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
GB8609537D0 (en) * 1986-04-18 1986-05-21 Ici Plc Polyesters
DE3720806C2 (de) * 1986-07-03 1997-08-21 Clariant Finance Bvi Ltd Verwendung eines Stabilisators in Peroxydbleichverfahren
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3641692A1 (de) * 1986-12-06 1988-06-09 Boehringer Ingelheim Kg Katalysatorfreie resorbierbare homopolymere und copolymere
DE3710175A1 (de) * 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
AU634723B2 (en) * 1988-08-08 1993-03-04 Biopak Technology, Ltd. Degradable thermoplastic from lactides
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US5424346A (en) * 1988-08-08 1995-06-13 Ecopol, Llc Biodegradable replacement of crystal polystyrene
BR8907604A (pt) * 1988-08-08 1991-07-30 Battelle Memorial Institute Composicao ambientalmente biodegradavel,processo para produzir a mesma e processo para tornar uma composicao de polimero termoplastico ambientalmente biodegradavel
US5180765A (en) * 1988-08-08 1993-01-19 Biopak Technology, Ltd. Biodegradable packaging thermoplastics from lactides
US5250584A (en) * 1988-08-31 1993-10-05 G-C Dental Industrial Corp. Periodontium-regenerative materials
JP2714454B2 (ja) * 1988-11-07 1998-02-16 三井東圧化学株式会社 生体吸収性ポリエステルの製造方法
US4990336A (en) * 1989-02-08 1991-02-05 Biosearch, Inc. Sustained release dosage form
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
DE4005415C2 (de) * 1990-02-21 1996-04-11 Boehringer Ingelheim Kg Verfahren zum Herstellen von Polyestern auf der Basis von Hydroxycarbonsäuren
US5288496A (en) * 1990-05-15 1994-02-22 Stolle Research & Development Corporation Growth promoters for animals
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US6353030B1 (en) * 1990-08-01 2002-03-05 Novartis Ag Relating to organic compounds
MY108621A (en) * 1990-08-01 1996-10-31 Novartis Ag Polylactide preparation and purification
NZ240214A (en) * 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
IT1249045B (it) * 1991-02-21 1995-02-11 Himont Inc Processo per la sintesi allo stato solido di polimeri dell'acido lattico e prodotti cosi ottenuti
US5247059A (en) * 1992-01-24 1993-09-21 Cargill, Incorporated Continuous process for the manufacture of a purified lactide from esters of lactic acid
US6326458B1 (en) 1992-01-24 2001-12-04 Cargill, Inc. Continuous process for the manufacture of lactide and lactide polymers
US6005067A (en) * 1992-01-24 1999-12-21 Cargill Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5247058A (en) * 1992-01-24 1993-09-21 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5142023A (en) * 1992-01-24 1992-08-25 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5258488A (en) * 1992-01-24 1993-11-02 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5294469A (en) * 1992-06-17 1994-03-15 Mitsui Toatsu Chemicals, Incorporated Industrial woven fabric and composite sheet comprising same
US5758053A (en) * 1992-07-22 1998-05-26 Hitachi, Ltd. Fault handling and recovery for system having plural processors
US5338822A (en) * 1992-10-02 1994-08-16 Cargill, Incorporated Melt-stable lactide polymer composition and process for manufacture thereof
DE69322155T2 (de) * 1992-10-02 1999-08-19 Cargill Papier mit einer beschichtung aus schmelzstabilem polymer und dessen verfahren zur herstellung
CA2124842C (en) * 1992-10-02 2003-07-15 Patrick R. Gruber A melt-stable lactide polymer fabric and process for manufacture thereof
US6005068A (en) * 1992-10-02 1999-12-21 Cargill Incorporated Melt-stable amorphous lactide polymer film and process for manufacture thereof
US5686092A (en) * 1992-11-24 1997-11-11 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
ATE288270T1 (de) * 1993-11-19 2005-02-15 Janssen Pharmaceutica Nv Mikroverkapselte 1,2-benzazole
EP0789045B1 (de) * 1995-08-29 2001-01-10 Kyowa Hakko Kogyo Co., Ltd. Verfahren zur herstellung von polyhydroxycarbonsäure
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
AU1732897A (en) * 1996-02-23 1997-09-10 Kyowa Hakko Kogyo Co. Ltd. Process for the preparation of polyhydroxycarboxylic acid
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6663899B2 (en) 1997-06-13 2003-12-16 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6733767B2 (en) 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
US6217844B1 (en) 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists
KR20020063208A (ko) 1999-12-10 2002-08-01 다우 글로벌 테크놀로지스 인크. 중축합 반응용 촉매 시스템
US6960626B2 (en) 2000-01-21 2005-11-01 Cyclics Corporation Intimate physical mixtures containing macrocyclic polyester oligomer and filler
US7256241B2 (en) 2000-01-21 2007-08-14 Cyclics Corporation Methods for polymerizing macrocyclic polyester oligomers using catalyst promoters
ES2256276T5 (es) * 2000-08-07 2011-02-22 Wako Pure Chemical Industries, Ltd. Polímero de ácido láctico y procedimiento para su producción.
US6362308B1 (en) 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
ATE407960T1 (de) * 2000-08-16 2008-09-15 Tyco Healthcare Absorbierendes polymerharz mit hoher konsistenz
AU2001288663A1 (en) 2000-09-01 2002-03-13 Cyclics Corporation Methods for converting linear polyesters to macrocyclic oligoester compositions and macrocyclic oligoesters
US7750109B2 (en) 2000-09-01 2010-07-06 Cyclics Corporation Use of a residual oligomer recyclate in the production of macrocyclic polyester oligomer
US7767781B2 (en) 2000-09-01 2010-08-03 Cyclics Corporation Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
CA2451187C (en) * 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
US7304123B2 (en) 2001-06-27 2007-12-04 Cyclics Corporation Processes for shaping macrocyclic oligoesters
JP2005515965A (ja) 2001-06-27 2005-06-02 サイクリクス コーポレイション 大環状オリゴエステルの単離、処方、および成形
TW200526267A (en) * 2001-06-29 2005-08-16 Takeda Chemical Industries Ltd Controlled release composition and method of producing the same
TWI225416B (en) 2001-06-29 2004-12-21 Takeda Chemical Industries Ltd Sustained-release composition and process for producing the same
US6787632B2 (en) 2001-10-09 2004-09-07 Cyclics Corporation Organo-titanate catalysts for preparing pure macrocyclic oligoesters
JP2003192773A (ja) * 2001-12-26 2003-07-09 Mitsui Chemicals Inc 生体吸収性ポリヒドロキシカルボン酸及びその製造法
US6849600B2 (en) * 2002-03-25 2005-02-01 The Regents Of The University Of California, Berkeley Corticotropin-releasing hormone analogs
KR100684682B1 (ko) * 2002-09-24 2007-02-22 아사히 가세이 케미칼즈 가부시키가이샤 글리콜산 공중합체 및 그의 제조 방법
EP1440992A1 (de) * 2003-01-21 2004-07-28 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Katalysatorzusammensetzung für die (Co)polymerisation von Lactid und Glycolid
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20050112087A1 (en) * 2003-04-29 2005-05-26 Musso Gary F. Pharmaceutical formulations for sustained drug delivery
EP1660039B1 (de) 2003-07-18 2016-09-28 Oakwood Laboratories L.L.C. Prävention von molekulargewichtreduktion des polymers, bildung von unreinheiten und gelierung in polymer-zusammensetzungen
US20050143303A1 (en) * 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
US20080318837A1 (en) * 2003-12-26 2008-12-25 Nastech Pharmaceutical Company Inc. Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
US20060210614A1 (en) * 2003-12-26 2006-09-21 Nastech Pharmaceutical Company Inc. Method of treatment of a metabolic disease using intranasal administration of exendin peptide
US20060074025A1 (en) * 2003-12-26 2006-04-06 Nastech Pharmaceutical Company Inc. Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
JP4817321B2 (ja) * 2004-04-28 2011-11-16 学校法人慶應義塾 主鎖にエステル結合を有するポリマーの解重合方法及び解重合生成物から主鎖にエステル結合を有するポリマーを製造する方法
ES2357243T3 (es) * 2004-05-21 2011-04-20 Micro Therapeutics, Inc. Espirales metálicas entrelazadas con polímeros o fibras biológicos o biodegradables o sintéticos para la embolización de una cavidad corporal.
US20070254314A1 (en) * 2004-09-16 2007-11-01 Geier Mark R Methods of treating autism and autism spectrum disorders
WO2006032291A1 (de) 2004-09-22 2006-03-30 Dendron Gmbh Vorrichtung zur implantation von mikrowendeln
DE102005019782A1 (de) * 2005-04-28 2006-11-09 Dendron Gmbh Vorrichtung zur Implantation von Okklusionswendeln mit innenliegendem Sicherungsmittel
US7342048B2 (en) * 2005-04-28 2008-03-11 Nipro Corporation Bioabsorbable pharmaceutical formulation
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US20070106271A1 (en) * 2005-11-09 2007-05-10 Searete Llc, A Limited Liability Corporation Remote control of substance delivery system
WO2007067964A2 (en) * 2005-12-08 2007-06-14 Nastech Pharmaceutical Company Inc. Mucosal delivery of stabilized formulations of exendin
EP3276349B1 (de) 2006-11-01 2019-08-07 Ventana Medical Systems, Inc. Haptene, haptenkonjugate, zusammensetzungen daraus und verfahren für ihre herstellung und verwendung
MY148370A (en) 2006-12-18 2013-04-15 Takeda Pharmaceutical Sustained-release composition and method for producing the same
JP5249249B2 (ja) 2007-03-13 2013-07-31 コヴィディエン リミテッド パートナーシップ コイルと耐伸張性部材とが含まれているインプラント
JP2011528379A (ja) 2008-07-17 2011-11-17 メリアル リミテッド ポリオルトエステルの安定性を増強する方法及びそれらの処方物
JP5718233B2 (ja) 2008-10-20 2015-05-13 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 甲状腺刺激ホルモン受容体（ｔｓｈｒ）の低分子量アゴニスト
CA2740970A1 (en) 2008-10-21 2010-04-29 Oregon Health & Science University Naphthamides as anticancer agents
CN101445595B (zh) * 2008-12-26 2011-01-19 上海新上化高分子材料有限公司 聚乙丙交酯及其制备方法和应用
US9365612B2 (en) 2010-01-29 2016-06-14 United States Of America As Represented By The Secretary, Department Of Health And Human Services Caspase inhibitors
JP5965387B2 (ja) 2010-04-08 2016-08-03 アメリカ合衆国 Ｔｓｈ受容体用のインバースアゴニストおよびニュートラルアンタゴニスト
WO2012125486A1 (en) 2011-03-11 2012-09-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Combination chemotherapy for treating cancer
US9446048B2 (en) 2011-03-17 2016-09-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins
CN102329269B (zh) * 2011-06-30 2013-07-17 南京大学 仿生氯化肌酐胍催化缩聚法合成高分子量聚乳酸
CN102295765B (zh) * 2011-06-30 2012-11-28 南京大学 生物质肌酐催化共缩聚法合成聚乳酸-乙醇酸
US20140348865A1 (en) 2011-09-12 2014-11-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Ser. Immunogens based on an hiv-1 v1v2 site-of-vulnerability
WO2013049535A2 (en) 2011-09-30 2013-04-04 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Influenza vaccine
WO2013106847A1 (en) 2012-01-13 2013-07-18 Oregon Health & Science University Compounds, compositions and associated methods comprising 3-aryl quinolines
PT2858975T (pt) 2012-06-08 2019-07-16 Univ Pittsburgh Commonwealth Sys Higher Education Inibidores de fbxo3
EP2919779B1 (de) 2012-11-13 2021-01-06 The U.S.A. as represented by the Secretary, Department of Health and Human Services Cannabinoid rezeptor mediatoren
US9775895B2 (en) 2012-12-12 2017-10-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services HIV therapeutics and methods of making and using same
EP4421177A3 (de) 2013-03-13 2024-12-18 The United States of America, as represented by the Secretary, Department of Health and Human Services Rsv-f-prefusionsproteine und deren verwendung
CN105611927A (zh) 2013-05-16 2016-05-25 美国政府(由卫生和人类服务部的部长所代表) 用于抑制耐药性hiv-1整合酶耐药株的化合物
CA2924527C (en) 2013-09-20 2022-07-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compounds for treating prostate cancer
US10398772B2 (en) 2014-01-08 2019-09-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy
WO2015172059A1 (en) 2014-05-09 2015-11-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Pyrazole derivatives and their use as cannabinoid receptor mediators
ES2914099T3 (es) 2014-08-25 2022-06-07 Salk Inst For Biological Studi Inhibidores novedosos de ULK1 y métodos de uso de los mismos
US10400015B2 (en) 2014-09-04 2019-09-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant HIV-1 envelope proteins and their use
WO2016064716A1 (en) 2014-10-20 2016-04-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Combination therapy of tshr antagonist and igfr inhibitor
US10420834B2 (en) 2014-12-24 2019-09-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant metapneumovirus F proteins and their use
EP3242661B1 (de) 2015-01-05 2019-08-21 The U.S.A. as represented by the Secretary, Department of Health and Human Services Myc-g-quadruplex-stabilisierende kleine moleküle und deren verwendung
PE20180021A1 (es) 2015-02-20 2018-01-09 Univ Oregon Health & Science Derivados de sobetiroma
EP3303325A1 (de) 2015-06-04 2018-04-11 The U.S.A. as represented by the Secretary, Department of Health and Human Services Cannabinoid-rezeptorvermittelnde verbindungen
AU2016274576A1 (en) 2015-06-11 2017-12-21 University Of Pittsburgh - Of The Commonwealth System Of Higher Education p62-ZZ chemical inhibitor
WO2017044803A1 (en) 2015-09-09 2017-03-16 The United States Of America, As Represented By The Secretary Department Of Health And Human Service Expression vector delivery system and use thereof for inducing an immune response
EP3423448B1 (de) 2016-03-04 2024-12-04 The U.S.A. as represented by the Secretary, Department of Health and Human Services Cannabinoid-rezeptorvermittelnde verbindungen
JP6900050B2 (ja) 2016-03-24 2021-07-07 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 去勢抵抗性前立腺がんの処置のためのアンドロゲン受容体の核移行の低分子阻害剤
MX382313B (es) 2016-05-18 2025-03-13 Univ Oregon Health & Science Derivados del sobetiroma.
EP3471828A1 (de) 2016-06-16 2019-04-24 Acies Bio d.o.o. Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch eine unzureichende pantothenatkinaseaktivität gekennzeichnet sind
WO2018109220A2 (en) 2016-12-16 2018-06-21 Institute For Research In Biomedicine Novel recombinant prefusion rsv f proteins and uses thereof
CA3053388C (en) 2017-02-22 2024-02-13 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Compounds and methods for inhibiting emt pathways to treat cancer, organ fibrosis and metabolic disorders
KR102688314B1 (ko) 2017-08-31 2024-07-26 에보닉 코포레이션 개선된 재흡수성 중합체 정제 방법
IL274130B2 (en) 2017-11-01 2025-08-01 Scripps Research Inst Novel scaffolded hiv-1 vaccine immunogens
WO2019118803A1 (en) 2017-12-14 2019-06-20 The United States Of America, As Represented By The Secretary,Department Of Health And Human Services Chemical entities for lytic activation of kshv and therapeutic targeting of viral enzymes/proteins
AU2019243561A1 (en) 2018-03-29 2020-09-24 Elex Biotech, Inc. Compounds for treatment of cardiac arrhythmias and heart failure
WO2020068657A1 (en) 2018-09-25 2020-04-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
EP3894383A1 (de) 2018-12-12 2021-10-20 Autobahn Therapeutics, Inc. Neuartige thyromimetika
CA3130371A1 (en) 2019-03-01 2020-09-10 Autobahn Therapeutics, Inc. Novel thyromimetics
EP3937917B1 (de) 2019-03-11 2023-11-15 Oregon State University Analoga und derivate von cephalotaxin und verfahren zur herstellung und verwendung der verbindungen
CN115279359A (zh) 2019-11-29 2022-11-01 速通医疗公司 新型拟甲状腺素药
US12594277B2 (en) 2020-02-14 2026-04-07 Salk Institute For Biological Studies Macrocyclic ULK1/2 inhibitors
EP4167986A4 (de) 2020-06-17 2024-11-20 Autobahn Therapeutics, Inc. Thyromimetika
EP4168384A4 (de) 2020-06-17 2024-07-10 Autobahn Therapeutics, Inc. Thyromimetika
AU2022271304A1 (en) 2021-05-06 2023-11-23 Autobahn Therapeutics, Inc. Fatty acid amide hydrolase (faah) cleavable prodrugs of thyromimetics and combination with peripherally restricted faah inhibitors
EP4352054A1 (de) 2021-06-09 2024-04-17 The United States of America, as represented by The Secretary, Department of Health and Human Services Verbindungen zur bindung nichtkanonischer g-quadruplex-strukturen und verfahren zur herstellung und verwendung davon
WO2023059867A1 (en) 2021-10-08 2023-04-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds for treating or preventing alzheimer's disease
WO2023146771A1 (en) 2022-01-25 2023-08-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gingerenone a prodrugs as senotherapeutics and methods of use
EP4493547A1 (de) 2022-03-14 2025-01-22 The United States of America, as represented by the Secretary, Department of Health and Human Services Verbindungen zur modulierung des cannabinoidrezeptors
WO2024151855A1 (en) 2023-01-13 2024-07-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bicyclic carbamoyl pyridone-based integrase strand transfer inhibitors
WO2025196270A1 (en) 2024-03-22 2025-09-25 Limmatech Biologics Ag Outer membrane vesicle vaccines for the prevention of n. gonorrhoeae and methods of making and using thereof
WO2025213007A1 (en) 2024-04-04 2025-10-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services S-hydroxychloroquine, optionally with tauroursodeoxycholic acid and/or 3,3'-diindolylmethane, for treating and/or preventing neurological disorders
WO2026085231A1 (en) 2024-10-16 2026-04-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Integrase strand transfer inhibitors
CN119979043A (zh) * 2025-04-15 2025-05-13 南京斯瑞奇医疗用品有限公司 一种双层复合的高透气性低敏胶带及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1995970A (en) * 1931-04-04 1935-03-26 Du Pont Polymeric lactide resin
US2362511A (en) * 1939-11-21 1944-11-14 Du Pont Modified glycolide resins
US2438208A (en) * 1943-07-10 1948-03-23 Us Agriculture Continuous process of converting lactic acid to polylactic acid
US2683136A (en) * 1950-10-25 1954-07-06 Du Pont Copolymers of hydroxyacetic acid with other alcohol acids
US2703316A (en) * 1951-06-05 1955-03-01 Du Pont Polymers of high melting lactide
US2758987A (en) * 1952-06-05 1956-08-14 Du Pont Optically active homopolymers containing but one antipodal species of an alpha-monohydroxy monocarboxylic acid
US3531561A (en) * 1965-04-20 1970-09-29 Ethicon Inc Suture preparation
US3498957A (en) * 1965-09-14 1970-03-03 Ethicon Inc Polymerization of cyclic carboxylic esters in the presense of a nonpolymerizable ester plasticizer
US3468853A (en) * 1966-06-15 1969-09-23 American Cyanamid Co Process of polymerizing a glycolide
BE758156R (fr) * 1970-05-13 1971-04-28 Ethicon Inc Element de suture absorbable et sa
US3839297A (en) * 1971-11-22 1974-10-01 Ethicon Inc Use of stannous octoate catalyst in the manufacture of l(-)lactide-glycolide copolymer sutures
US4137921A (en) * 1977-06-24 1979-02-06 Ethicon, Inc. Addition copolymers of lactide and glycolide and method of preparation
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions

Also Published As

Publication number Publication date
SG108191G (en) 1992-06-12
CA1236641A (en) 1988-05-10
ATE39935T1 (de) 1989-01-15
EP0172636A1 (de) 1986-02-26
DE3567470D1 (en) 1989-02-16
EP0171907B1 (de) 1989-01-11
EP0171907B2 (de) 1994-08-10
CA1256638A (en) 1989-06-27
US4677191A (en) 1987-06-30
BG61520B2 (bg) 1997-10-31
US4683288A (en) 1987-07-28
EP0171907A1 (de) 1986-02-19
EP0172636B2 (de) 1992-11-11
DE3567471D1 (en) 1989-02-16
EP0172636B1 (de) 1989-01-11
HK19592A (en) 1992-03-20

Similar Documents

Publication Publication Date Title
ATE39935T1 (de) Copolymer und verfahren zu seiner herstellung.
US4379138A (en) Biodegradable polymers of lactones
ATE106913T1 (de) Verfahren zur herstellung eines polymeren lactids.
US5250584A (en) Periodontium-regenerative materials
BE1002656A5 (fr) Matieres regeneratrices du perioste dentaire.
ATE250663T1 (de) Kulturmedium und verfahren zur herstellung von hyaluronsäure mit hohem molekulargewicht
SE9100610D0 (sv) Bioresorbable material for medical use
PT87455B (pt) Processo para a preparacao de aplicadores biodegradaveis para tampoes higienicos e aplicadores biodegradaveis produzidos por esse processo
ATE258685T1 (de) Makromolekulare mikropartikel und verfahren zur ihrer herstellung
MXPA02003890A (es) Polianhidridos con products de degradacion activos biologicamente.
NO921421L (no) Kopolymermateriale med lav molekylvekt omfattende polymermonoalkylfosfinat og monoalkylfosfonat samt fremgangsmaatetil fremstilling derav
FR2623402B1 (fr) Article en polymere d'acide lactique utilisable notamment comme prothese biodegradable et procede pour sa realisation
DE3886906D1 (de) Herstellung von wässerigen Fluor-Polymerzusammensetzungen.
DE69330163D1 (de) Reaktive viskose olefinpolymere und copolymere mit niedrigem molekulargewicht und verfahren zur herstellung davon
ATE22693T1 (de) Verfahren zur herstellung von 4-methyl-1-penten- polymeren oder -copolymeren.
ATE145830T1 (de) Weicher elastischer und bioabsorbierbarer film aus milchsäurepolymer, insbesondere verwendbar zur herstellung von medizinischen verbänden
DE68920779D1 (de) Verfahren zur Herstellung von Polymeren.
ATE79888T1 (de) Hydroxylgruppenhaltige copolymerisate auf der basis von vinylester-, vinylaromat- und hydroxylalkylester-monomeren, verfahren zu ihrer herstellung sowie ihre verwendung in beschichtungsmitteln.
EP1211268A4 (de) Statistisches copolymer, verfahren zu dessen herstellung und medizinisches material
ATE84050T1 (de) Verfahren zur herstellung von glutaranhydrid enthaltenden copolymeren.
ES8105567A1 (es) Procedimiento para la obtencion de nuevas composiciones endurecibles dentales, protesicas y otras.
ATE153353T1 (de) Verfahren zur herstellung eines von milchsäure abgeleiteten polyurethans
KR910006386A (ko) 수지 성형체의 정전 도장 방법
ATE29386T1 (de) Verwendung eines sulfonierten homo- oder copolymeren des styrols zur herstellung eines antikonzeptionsmittels.
EP0257567A3 (en) Resin-fortified emulsion polymers and methods of preparing the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee